RECENT NEWS
CardioRenal receives FDA Breakthrough Device Designation for TENOR
CardioRenal, a pioneer in the remote treatment of patients with severe chronic kidney disease (CKD), has announced that its TENOR device has obtained Breakthrough Device Designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA).
Cellular Origins launches Constellation automated cell therapy platform
Cellular Origins has launched Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023. Designed to automate the manufacturing of advanced therapies without significant process redevelopment, Constellation combines aseptic fluid handling technologies with advanced automation.
Avacta acquires Coris Bioconcept
Avacta, a life sciences company developing targeted oncology drugs and diagnostics, has acquired Belgian firm Coris Bioconcept which develops, manufactures and markets rapid diagnostic test kits.
Blood biomarker can help predict Alzheimer’s - study
New research has revealed further details of how Alzheimer’s disease is caused, and a blood test could predict who will go on to develop the condition. A new paper published in Nature Medicine by staff at the University of Pittsburgh School of Medicine found that the build-up of amyloid protein in the brain, long associated with the disease, may in itself not be enough to cause symptoms.
MHRA announces new routes for medicine approval via international partners
New regulatory recognition routes for medicines will be established using approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced.
PathPresenter passes 50,000 global users
PathPresenter, the global image sharing platform for pathology, has announced that its free public platform now has more than 50,000 registered users in 172 countries. Nearly 7,000 users have joined the pathology image sharing community in the past 12 months.
IBMS publishes 2022 Annual Report
The Institute of Biomedical Science (IBMS) has published its 2022 Annual Report, reflecting on the support it is providing its members and how it is using its channels to raise awareness of biomedical science.
Validair Monitoring Solutions rebrands as FMS
Validair Monitoring Solutions has chosen to rebrand its business and has changed its name to FMS. The move comes as the company expands into new sectors with facility-wide and cleanroom airborne particle monitoring increasingly relevant in markets beyond the pharmaceutical industry.
Menarini launches PRIME MDx platform
A. Menarini Diagnostics has launched its new PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through real-time PCR.
MHRA and Genomics England to launch biobank for medicine research
A brand-new genetic research resource, known as a ‘biobank’, will be piloted by the Medicines and Healthcare products Regulatory Agency (MHRA) in a joint venture with Genomics England to better understand how a patient’s genetic makeup can impact the safety of their medicines.
IBMS, RCPath and ACB collaborate for POCT guidance
The Institute of Biomedical Science (IBMS) has collaborated with The Royal College of Pathologists (RCPath) and The Association for Clinical Biochemistry and Laboratory Medicine (ACB) to produce a strategy document aimed at those responsible for planning and commissioning novel patient services outside of traditional care settings.
RCPath chooses Dr Bernie Croal as President Elect
Dr Bernie Croal has been elected by the College membership as President Elect of The Royal College of Pathologists.
Roche showcasing innovative diagnostic solutions at EuroMedLab
At EuroMedLab 2023 in Rome, Roche has introduced the next generation of its serum work area, several molecular systems and the cobas connection module. Also on show is the new navify digital solution to help laboratories address their needs for digital infrastructure, operational excellence and medical insights.
Genomic testing for rare disease: a two-week online course
The National Genomics Education programme is running a free two-week online course which offers a practical guide to the genomic testing process for rare disease.
bioMérieux launches Sepsis Summit events
As part of its commitment to public health, bioMérieux has announced two upcoming events focused on sepsis and the blood culture pathway. The Irish Sepsis Summit takes place 21 June in Athlone, with the UK Sepsis Summit following on 5-6 September, at the University of Nottingham.
NHS to pioneer blood test to aid patients with blood disorders
The NHS is set to introduce a new genetic blood-matching test for thousands living with sickle cell disease or thalassaemia that could reduce some of the side effects of transfusion treatments.
Labgnostic goes live with agnostic laboratory exchange network
UK company X-Lab has launched a successful pilot of its Labgnostic software between TriCore and Arkana Labs to enable interoperability between diagnostic laboratories. X-Lab which owns and operates a systems-agnostic laboratory exchange hub, called Labgnostic, has recently gone 'live' in connecting the first two US laboratories to the network.
Sphere Fluidics updates branding
Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, has recently revealed its new branding to align with its ambitious global commercial growth strategy.
Paige introduces integration capabilities to the Paige Platform
Digital pathology solutions and clinical AI firm Paige has introduced new advanced integration capabilities to the Paige Platform, a holistic web-based solution that enables complete digital pathology workflows and supports the evolving needs of today’s modern laboratory.
Revvity announces licence agreement for Pin-point base editing system
Revvity has announced a new licence agreement with AstraZeneca for the technology underlying its Pin-point base editing system, a next-generation modular gene editing platform with a strong safety profile.
Featured Supplier
BD offers a flexible and scalable approach to IV barcoding with the Alaris™ Auto-ID module. This unique barcoding device narrows the uncertainty between the right drug and right patient and also helps to ensure that only authorized hospital personnel administer the medication providing an additional safety net for all pump, syringe and PCA...
Upcoming Events
IBMS Congress 2023 - Linking learning to the laboratory
ICC Birmingham
25-28 September 2023
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
